Against Experts' Concerns, HHS Releases A New Autism Study

Against Experts' Concerns, HHS Releases A New Autism Study

Credits: Canva and Gilbert Carrasquillo

Text

Updated Apr 12, 2025 | 08:00 AM IST

SummaryAfter RFK Jr.'s announcement to carry out a study to find causes for autism, HHS has not released any detailed plans for the study, leaving many questions about its direction, scientific credibility, and impact.

End of Article

New Progesterone Device Offers Hope To Women Facing Threatened Miscarriages

New Progesterone Device Offers Hope To Women Facing Threatened Miscarriages

Credit: Canva

Text

Updated Apr 12, 2025 | 10:04 PM IST

SummaryProgesterone plays a crucial role in early pregnancy, helping to prepare and support the womb for a growing baby.

End of Article

RFK Jr. Says New HHS Research Could Solve ‘Autism Epidemic’ By September- Could This Change Treatment?

RFK Jr. Says New HHS Research Could Solve ‘Autism Epidemic’ By September- Could This Change Treatment?

Text

Updated Apr 12, 2025 | 06:11 PM IST

SummaryAutism affects about 1 in 36 children in the U.S., according to the CDC. While the exact cause remains unclear, experts agree it’s a complex interplay of genetics and environment—not vaccines.

End of Article

Know All About The Recently Approved Landmark Breast Cancer Drug In UK

Know All About The Recently Approved Landmark Breast Cancer Drug In UK

Credits: Canva

Text

Updated Apr 12, 2025 | 01:00 PM IST

SummaryCapivasertib is taken as a twice-daily pill, in combination with the hormone therapy fulvestrant. The drug works by blocking an abnormal protein—a part of the cancer cell’s signaling system—that tells the cells to multiply. By disrupting this signal, capivasertib slows or halts the progression of the disease.

End of Article